PenRad Technologies Revenue and Competitors

Buffalo, MN USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • PenRad Technologies's estimated annual revenue is currently $870k per year.(i)
  • PenRad Technologies's estimated revenue per employee is $87,000

Employee Data

  • PenRad Technologies has 10 Employees.(i)
  • PenRad Technologies grew their employee count by -33% last year.

PenRad Technologies's People

NameTitleEmail/Phone
1
Senior Executive — VP — Information Security OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M249%N/AN/A
#2
$9.1M700%N/AN/A
#3
$28.4M1782%N/AN/A
#4
$1M12-14%N/AN/A
#5
$0.9M10-17%N/AN/A
#6
$0.7M9-18%N/AN/A
#7
$84.6M4672%N/AN/A
#8
$0.1M20%N/AN/A
#9
$0.3M4300%N/AN/A
#10
$3.5M30-12%N/AN/A
Add Company

What Is PenRad Technologies?

Creates software with an interface that utilizes touch monitors, touch screens, and mouse clicks, reducing the need for a keyboard. Product offers instantaneous automated reports; multiple statistical reports; addendum/dictation capabilities; internalized film tracking; compliance with MQSA; automated patient correspondences; tracking of resolved / unresolved exams; specific detailing of abnormalities; elimination of dictation/transcription.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$870k

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PenRad Technologies News

2022-04-17 - Lung Cancer Screening Software Market Report: Top Players ...

... increased focus of technological advancements involved in the ... software market report are Medtronic, PenRad Technologies Inc.,...

2022-03-30 - Global Specialty PACS Market Size, Share & Industry Trends Analysis Report By Deployment Model, By Type, By End User, By Regional Outlook and Forecast, 2021 - 2027

The PACS systems are one of such technological advancements. ... The partnership aimed to integrate PenRad 's lung screening platform,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.1M100%N/A
#2
$1.2M100%N/A
#3
$0.9M10100%N/A
#4
$0.9M10-9%N/A
#5
$1M1122%N/A